92 related articles for article (PubMed ID: 7503938)
1. Factors affecting production of antibodies to prostate antigens by in vitro-primed human splenocytes.
Lu EW; Bustria AT; Royston I; Brams P
Hybridoma; 1993 Aug; 12(4):381-9. PubMed ID: 7503938
[TBL] [Abstract][Full Text] [Related]
2. In vitro immunization. Effect of growth and differentiation factors on antigen-specific B cell activation and production of monoclonal antibodies to autologous antigens and weak immunogens.
Borrebaeck CA; Möller SA
J Immunol; 1986 May; 136(10):3710-5. PubMed ID: 3486221
[TBL] [Abstract][Full Text] [Related]
3. Inducing a humoral immune response to pancreatic cancer antigen.
Seifert M; Seifert G; Wolff-Vorbeck G; Langenmair E; Hopt UT; Wittel UA
Cell Immunol; 2016 Dec; 310():150-155. PubMed ID: 27663207
[TBL] [Abstract][Full Text] [Related]
4. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody that defines the prostate specific antigen.
Donn F; Bruns T; von Meyerinck L; Schulz M; Becker WM; Becker H; Klosterhalfen H
Prostate; 1989; 14(3):237-49. PubMed ID: 2471963
[TBL] [Abstract][Full Text] [Related]
6. In vitro priming of human lymphocytes. I. IL-2 and IL-4 requirements.
Brams P; Royston I; Boerner P
Hum Antibodies Hybridomas; 1993 Apr; 4(2):47-56. PubMed ID: 8518365
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of monoclonal antibodies against prostate-specific antigen.
Karuppaiya A; Cheah SH; Mohd S; Kamal WH; Zulkifli MH
Hybridoma (Larchmt); 2009 Apr; 28(2):133-7. PubMed ID: 19249990
[TBL] [Abstract][Full Text] [Related]
8. Production of antigen-specific human monoclonal antibodies from in vitro-primed human splenocytes.
Boerner P; Lafond R; Lu WZ; Brams P; Royston I
J Immunol; 1991 Jul; 147(1):86-95. PubMed ID: 2051030
[TBL] [Abstract][Full Text] [Related]
9. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
10. Immunization of normal human splenocytes in vitro to produce human monoclonal antibodies to cellular antigens.
Hulette CM; Effros RB; Walford RL
Tissue Antigens; 1987 Jul; 30(1):25-33. PubMed ID: 3672490
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to the prostate specific antigen.
Donn F; Bruns T; von Meyerrinck L; Augustin C; Schulz M; Klosterhalfen H; Schmoldt A
Andrologia; 1990; 22 Suppl 1():44-55. PubMed ID: 1720289
[TBL] [Abstract][Full Text] [Related]
12. Influence of antigen presentation and exogenous cytokine activity during in vitro primary immunizations employed for the generation of monoclonal antibodies.
Halabi G; McCullough KC
J Immunol Methods; 1995 Oct; 186(2):205-16. PubMed ID: 7594620
[TBL] [Abstract][Full Text] [Related]
13. Human monoclonal IgM antibodies from foetal B-cell hybridomas directed against a surface antigen on human tumour cells.
Bohn J; Josimovic-Alasevic O; Settmacher U; Kiessig ST; Lukowsky A; Volk HD; Diamantstein T; Von Baehr R; Jahn S
Res Immunol; 1992; 143(9):879-91. PubMed ID: 1289988
[TBL] [Abstract][Full Text] [Related]
14. Production of monoclonal and polyclonal antibodies against prostate-specific antigen, a prostate cancer serum marker.
Chou SF; Chen CY
Hybrid Hybridomics; 2004 Feb; 23(1):73-7. PubMed ID: 15000852
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
[TBL] [Abstract][Full Text] [Related]
16. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U
Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM.
Bogdan CA; Alexander AA; Gorny MK; Matute R; Marjanovic N; Zolla-Pazner S; Walden PD; Furneaux HM; Sidhu GS; Jacobson DR
Cancer Res; 2003 May; 63(9):2067-71. PubMed ID: 12727821
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
19. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
20. The in vitro antibody response to cell surface antigens. II. Monoclonal antibodies to human leukemia cells.
Levy R; Dilley J
J Immunol; 1977 Aug; 119(2):394-400. PubMed ID: 301891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
